Donate to the My Cleats campaign Donate

1st

Drug approved by the FDA
for the treatment of Duchenne.
CureDuchenne was an early funder.

9

CureDuchenne funded research projects
have advanced to human clinical trials

BE A MEMBER OF OUR PATIENT REGISTRY

Enroll here to make sure you’re alerted and aware of the latest pharmaceutical treatments for Duchenne muscular dystrophy that become available as research progresses every day.

Our lives were changed forever…

“We didn’t know anything about Duchenne and felt isolated that there was no one we could turn to… CureDuchenne has hosted several workshops that have been invaluable in providing knowledge on the care, treatment and future of our son, but, even more importantly, has enabled us to spend time with other Duchenne families…”

READ FAMILY STORY

Duchenne is a devastating muscle disease.

It’s the most common and severe form of muscular dystrophy. Those affected with Duchenne lose their ability to walk, feed themselves, breath independently and succumb to heart failure. But there’s hope through new pharmacological and gene-based therapies. You can help make a difference.

LEARN ABOUT THE DISEASE

UPCOMING EVENTS, WORKSHOPS & WEBINARS

03March
03 March @ 05:00 pm - 10:00 pm

Napa In Newport

For the wine connoisseur who appreciates the earthen opulence of wine country, cult brands, exquisite cuisine, and unparalleled auction lots, Southern California’s premier wine event is back for the 4th Annual Napa in Newport benefiting CureDuchenne.

Napa In Newport

For the wine connoisseur who appreciates the earthen opulence of wine country, cult brands, exquisite cuisine, and unparalleled auction lots, Southern California’s premier wine event is back for the 4th Annual Napa in Newport benefiting CureDuchenne.

05:00 pm - 10:00 pm
1 Ritz Carlton Dr.
03March
Learn More

DUCHENNE ARTICLES

ANAHEIM, Calif., Nov. 15, 2017 /PRNewswire/ — Boys and young men in advanced stages of Duchenne muscular dystrophy experienced significant and sustained improvements in cardiac structure and function, as well as skeletal muscle function, following treatment with CAP-1002, the lead investigational therapy under development at Capricor Therapeutics (NASDAQ: CAPR). These findings were reported today by […]

CURE DUCHENNE NEWS

Matches Donations to Fund Duchenne Research NEWPORT BEACH, CA (December 2, 2017) – In Week 13 of the NFL season, Clay Matthews of the Green Bay Packers will take to the field with his heart on his feet. This year, the NFL is continuing its ‘My Cause My Cleats’ campaign where NFL players design cleats […]

SPONSORS